Alto Neuroscience, Inc. — Form 8-K
Filed August 27, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 72/100
What the filing says
Alto Neuroscience promoted CFO Nicholas C. Smith to President and CFO effective August 26, 2026. Smith receives a $6M retention payment in two equal $3M installments (first within 10 days, second on one-year anniversary), contingent on continuous employment through August 26, 2028. If Smith resigns or is terminated for Cause before the retention date, he must repay all amounts received; if terminated without Cause or due to death/disability, remaining payments are owed.
Why this rating
Retention package ($6M) equals ~11% of company's $55.2M market cap. Leadership continuity matters for small-cap biotech, but promotion is internal with standard clawback terms, reducing downside risk.
Price action (we called it neutral)
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from August 27, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.